Nexobrid Purple Book BLA 761192
- BLA number
- 761192
- Proprietary names
- Nexobrid
- Proper names
- anacaulase-bcdb
- Applicant
- Vericel Corporation
- Center
- CDER
- First observed release
- 2023-01-01
- Latest observed release
- 2026-06-01
- Newest archive release
- 2026-06-01
- FDA patent list
- No patents listed in the captured FDA patent list; source updated 2025-06-11
- Coverage
- Present in newest release
Latest Known Product Presentations#
Product, Proprietary name, Proper name table| Product | Proprietary name | Proper name | License type | Strength | Dosage form | Route | Presentation | Marketing | Licensure | Approval | Patent list provided |
|---|
| 001 | Nexobrid | anacaulase-bcdb | 351(a) | 8.8% (1.94GM) | For Topical Gel | Topical | Single-Use Jar | Disc | Licensed | 2022-12-28 | |
| 002 | Nexobrid | anacaulase-bcdb | 351(a) | 8.8% (4.85GM) | For Topical Gel | Topical | Single-Use Jar | Rx | Licensed | 2022-12-28 | |
Published Patent List#
No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.
Official Monthly Change Events#
Release, Event, Product table| Release | Event | Product | Name | License type | Status | Applicant |
|---|
| 2024-12-01 | U | 001 | Nexobrid | 351(a) | Disc | Vericel Corporation |
| 2024-11-01 | U | 001 | Nexobrid | 351(a) | Rx | Vericel Corporation |
| 2024-11-01 | U | 002 | Nexobrid | 351(a) | Rx | Vericel Corporation |
| 2024-08-01 | U | 001 | Nexobrid | 351(a) | Rx | Vericel Corporation |
| 2024-08-01 | U | 002 | Nexobrid | 351(a) | Rx | Vericel Corporation |
| 2023-10-01 | U | 001 | Nexobrid | 351(a) | Rx | MediWound, Ltd. |
| 2023-10-01 | U | 002 | Nexobrid | 351(a) | Rx | MediWound, Ltd. |
| 2023-07-01 | U | 001 | Nexobrid | 351(a) | Disc | MediWound, Ltd. |
| 2023-07-01 | U | 002 | Nexobrid | 351(a) | Disc | MediWound, Ltd. |
| 2023-04-01 | U | 001 | Nexobrid | 351(a) | Rx | MediWound, Ltd. |
| 2023-04-01 | U | 002 | Nexobrid | 351(a) | Rx | MediWound, Ltd. |
| 2023-01-01 | N | 001 | Nexobrid | 351(a) | Rx | MediWound, Ltd. |
| 2023-01-01 | N | 002 | Nexobrid | 351(a) | Rx | MediWound, Ltd. |
Observed Product State History#
Release, Product, Name table| Release | Product | Name | License type | Marketing | Licensure | Approval |
|---|
| 2024-12-01 | 001 | Nexobrid | 351(a) | Disc | Licensed | 2022-12-28 |
| 2023-10-01 | 001 | Nexobrid | 351(a) | Rx | Licensed | 2022-12-28 |
| 2023-10-01 | 002 | Nexobrid | 351(a) | Rx | Licensed | 2022-12-28 |
| 2023-07-01 | 001 | Nexobrid | 351(a) | Disc | Licensed | 2022-12-28 |
| 2023-07-01 | 002 | Nexobrid | 351(a) | Disc | Licensed | 2022-12-28 |
| 2023-01-01 | 001 | Nexobrid | 351(a) | Rx | Licensed | 2022-12-28 |
| 2023-01-01 | 002 | Nexobrid | 351(a) | Rx | Licensed | 2022-12-28 |